1Ruggeri L, Mancnsi A, Burchielli E, et aL Natural killer cell all- oreactivity in allogenei chematopoietie transplantation[J]. Curt Opin Oneol, 2007, 19(2):142-147.
2Maghazachi A A. Role of ehemokines in the biology of natural killer ceUs[J]. Curt Top Microbiol lmmunol, 2010, 341:37-58.
3Vacca P, Martini S, GareUi V, et al. NK cells from malignant pleural effusions are not anergic but produce cytokines and display strong anti-tumor activity on short-term IL-2 activation[J]. Eur J Immtmol, 2012, 27:783.
4Costello R T, Sivori S, Marcenaro E, et al. Defective expression and function of natural killer cell-triggering receptors in patients with acute myeloid leukemia[J]. Blood, 2002, 99(10):3661-3667.
5Sanchez C J, Le Treut T, Boehrer A, et al. Natural killer ceils and malignant haemopathies: a model for the interaction of cancer with innate immunity[J]. Cancer Immunol Immnnother, 2011, 60(1): 1-13.
6Rey J, Veuillen C, Vey N, et al. Natural killer and 78 T cells in haematological malignancies:enhancing the immune effectors[J]. Trends Mol Med, 2009, 15(6): 275-284.
7Yokose N, Ogata K, Ito T, et al. Elevated plasma soluble interleukin 2 receptor level correlates with defective natural killer and CD8+ T- cells in myelodysplastic syndromes[Y]. Leuk Res, 1994, 18(10): 777- 782.
8Dcmanet C, Mulder A, Dcneys V, ct al. Down-regulation of HLA-A and HLA-Bw6, but not HLA-Bw4, allospecificities in leukemic cells: an escape mechanism from CTL and NK attack?[J]. Blood, 2004, 103(8): 3122-3130.
9Maki G, Hayes G M, Naji A, et al. NK resistance of tumor cells from multiple myeloma and chronic lymphocytic leukemia patients:im- plication of HLA-G[J]. Leukemia, 2008, 22(5): 998-1006.
10Challa-MaUadi M, Lieu Y K, Califano O, et al. Combined genetic inactivation of i2-microglobulin and CD58 reveals frequent escape from immune recognition in diffuse large B cell lymphorna [J]. Cancer Cell, 2011, 20( 6):728-740.
同被引文献44
1Shen Y, Lu C, Tian W, et al. Possible association of decreased NKG2D expression levels and suppression of the activity of natural killer cells in patients with colorectal cancer [ J ], Iut J Oncol, 2012,40(4) :1285 - 1290.
2Chart CJ, Andrews DM, MeLaughlin NM, et al. DNAM - 1/CD155 interactions promote cytokine and NK cell - mediated suppression of poorly immunogenic melanoma metastases [ J ]. J Immuno1,2010, 184(2) :902 -911.
3Shakhar G, Ben - Eliyahu S. Potential prophylactic measures a- gmnst postoperative lmmunosnppresslor rence rates in oncological patients [ J ]. (8) :972 - 992. :could they reduce recur- Ann Surg Oncol,2003,10.
4G Hodeg, J Bamawi, C Jurisevic, et al. Lung cancer is associated with decreased expression of perforin, granzyme B and interferon (IFN) - ~, by infiltrating lung tissue T ceils, natural killer (NK) T - like and NK cells[ J]. Clin Exp Immunol,2Olg, 178 ( 1 ) :79 - 85.
5Frese -Schaper M,Keil A,Yagita I-I,et al. h~fluence of natural kil- ler cells and perforinmediated cytolysis on the development of chemically induced lung cancer in A/J mice [ J ]. Cancer Immunol Immunother,2014,63 (6) :571 - 580.
6Lee JC, Lee KM, Kim DW, et al. Elevated TGF - betal secretion and down - modulation of NKG2D underlies impaired NK cytotox- icity in cancer patients [ J ]. J Immunol, 2004,172 ( 12 ) : 7335 - 7340.
7Kollipara PS, Won dH, Hwang C J, et al. Enhanced anti - cancer effect of snake venom activated NK cells on lung cancer ceils by in- activation of NF - kappaB [ J ]. Biomol Ther ( Seoul), 2014,22 (2) :106 -113.
8Zhang G, Zhao H, Wu J, et al. Adoptive immunotherapy for non - small cell lung cancer by NK and cytotoxic T lymphocytes mixed effector cells : retrospective clinical observation [ J ]. Int Immunop- harmacol,2014,21 (2) :396 -405.
9Smyth MJ, Dunn GP, Schreiber RD. Cancer immunosurveillance and immunoediting: the roles of immunity in suppressing tumor development and shaping tumor immunogenicity [ J ]. Adv Immu- no1,2006,90 : 1 - 50.
10Mamessier E, Bourgin C, Olive D. When breast cancer cells start to fend the educational process of NK cells off[ J]. Oncoimmunol- ogy ,2013,2(12) : e26688.
